PHAGERIARUS

Serial Number 90667892
Registration 7172143
700

Registration Progress

Application Filed
Apr 23, 2021
Under Examination
Jul 18, 2023
Approved for Publication
May 23, 2023
Published for Opposition
May 23, 2023
Registered
Sep 26, 2023

Trademark Image

PHAGERIARUS

Basic Information

Serial Number
90667892
Registration Number
7172143
Filing Date
April 23, 2021
Registration Date
September 26, 2023
Published for Opposition
May 23, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 26, 2023
Registration
Registered
Classes
042

Rights Holder

iNtRON Biotechnology, Inc.

03
Address
#701-704 Jungang Induspia
138-6 Sangdaewon-dong, Joongwon-ku
Sungnam-si,Kyeonggi-do 462-120
KR

Ownership History

iNtRON Biotechnology, Inc.

Original Applicant
03
Sungnam-si,Kyeonggi-do KR

iNtRON Biotechnology, Inc.

Owner at Publication
03
Sungnam-si,Kyeonggi-do KR

iNtRON Biotechnology, Inc.

Original Registrant
03
Sungnam-si,Kyeonggi-do KR

Legal Representation

Attorney
Lawrence K. Nodine

USPTO Deadlines

Next Deadline
1419 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-26)
Due Date
September 26, 2029
Grace Period Ends
March 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Sep 26, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 26, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 22, 2023 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Aug 22, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 21, 2023 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jul 21, 2023 D1BR I TEAS DELETE 1(B) BASIS RECEIVED Loading...
Jul 18, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 23, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 23, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 3, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 15, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 14, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 13, 2023 ALIE A ASSIGNED TO LIE Loading...
Jan 18, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 4, 2022 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Aug 4, 2022 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Aug 4, 2022 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jul 8, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Dec 21, 2021 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Dec 21, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Dec 21, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 17, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 30, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 27, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products

Classification

International Classes
042